电化学联合平阳霉素局部注射治疗舌血管畸形  

Electrochemical Therapy Combined with Pingyangmycin Injection for the Treatment of Tongue Vascular Malformation

作　　者：张明慧 宋佳[1] 乔祺惠 王绪凯[1] ZHANG Minghui;SONG Jia;QIAO Qihui;WANG Xukai(Department of Oral and Maxillofacial Surgery,Hospital of Stomatology,China Medical University,Shenyang 110000,Liaoning Province,China)

机构地区：[1]中国医科大学附属口腔医院口腔颌面外科

出　　处：《口腔颌面外科杂志》2020年第1期28-32,共5页Journal of Oral and Maxillofacial Surgery

基　　金：辽宁省教育厅资助项目(2009A747)

摘　　要：目的 :探讨电化学联合平阳霉素局部注射治疗舌血管畸形的临床疗效。方法 :回顾2013-01—2018-05期间,在我院接受电化学联合平阳霉素局部注射治疗的舌血管畸形患者54例,病变大小为2 cm×3 cm^7 cm×9 cm,其中高流速血管畸形16例。根据病变大小给予电化学治疗量为5~10 C/cm2,平阳霉素注射量为3~5mL。术后给予抗生素和激素治疗。结果:随访1~5年,54例患者均有不同程度的改善,有效率达100%。患者术后常发生局部疼痛、肿胀等症状,症状一般于5~7 d后消失。所有患者术后主观感觉及舌体运动正常。结论:电化学联合平阳霉素局部注射治疗舌血管畸形安全有效,并发症少,值得临床推广。Objective:To evaluate the clinical outcomes of electrochemical therapy combined with pingyangmycin injection for the treatment of tongue vascular malformation(VM).Methods:During the period from January 2013 to May 2018,a total of 54 patients with VM of the tongue were treated by electrochemical therapy with pingyangmycin injection and were retrospectively examined.Size of the lesions ranged from 2 cm×3 cm to 7 cm×9 cm,including 16 cases of high-flow vascular malformation of the tongue.According to the size of the lesion,5-10 C/cm2 of electricity were selected,the dose of pingyangmycin injection were 3-5 mL.Routine anti-inflammatory and hormonal treatments were done after the operation.Results:At the follow-up period varied from 1 year to 5 years,54 patients achieved different degree of improvement,with an effective rate of 100%.All patients complained different degree of pain and swelling after operation,which subsided in 5 to 7 days.Postoperative subjective sensation and function of the tongue were normal.Conclusion:Electrochemical therapy with pingyangmycin injection was a reliable and security method for the management of vascular malformation of tongue.The complications were slight,and the approach should be promoted.

关 键 词：血管畸形 舌 电化学治疗 平阳霉素 

分 类 号：R739.8[医药卫生—肿瘤]